Results 171 to 180 of about 23,985 (238)

Virology: An Oncolytic Virus [PDF]

Nature New Biology, 1971
openaire   +1 more source

Enhanced oral nanomedicine utilizing biomineralized oncolytic virus for synergistic gastrointestinal cancer therapy. [PDF]

Mater Today Bio
Hu Z, Sun Y, Yu S, Zheng F, Yan Z, Lu N, Ye L, Yuan S, Zhu Y, Deng J, Wang J, Bai Y.   +11 more
europepmc   +1 more source

Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors. [PDF]

J Immunother Cancer
Villano JL, Luke JJ, Julian R, Fountzilas C, Patel MR, Chisamore MJ, Bhattacharya P, Takeshita S, Soukharev S, Yamada S, Zhang L, Wentzel KP.   +11 more
europepmc   +1 more source

Opportunities, challenges, and future perspectives of oncolytic virus therapy for malignant melanoma. [PDF]

Front Immunol
Wang JW, Feng Q, Liu JH, Xun JJ.
europepmc   +1 more source

Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges. [PDF]

Semin Immunol
Piranlioglu R, Chiocca EA.
europepmc   +1 more source

Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration. [PDF]

Cancers (Basel)
Sarkisova VA, Dalina AA, Neymysheva DO, Zenov MA, Ilyinskaya GV, Chumakov PM.   +5 more
europepmc   +1 more source

Oncolytic virus VG161 offers new hope for refractory liver cancer. [PDF]

Front Oncol
Li J, Zhou H, Wang X, Huang K, Wang Y.
europepmc   +1 more source

Efficacy, Safety and Predictive Biomarkers of Oncolytic Virus Therapy in Solid Tumors: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
El-Tanani M, Rabbani SA, Patni MA, Babiker R, Satyam SM, Rangraze IR, Wali AF, El-Tanani Y, Porntaveetus T.   +8 more
europepmc   +1 more source

Myeloid-derived suppressor cells inhibit the replication of oncolytic virus by reducing intratumoral arginine levels. [PDF]

Mol Ther Oncol
Dryja P, Flores EB, Bartee MY, Palanisamy V, Bartee E.   +4 more
europepmc   +1 more source

KLS-3021, a multifunctional oncolytic virus, demonstrates potent early-intervention efficacy in preclinical models of prostate-confined and locally advanced prostate cancer. [PDF]

Front Oncol
Seo J, Park K, Lee S, Kang H, Kim J, Lee E, Shin J, Hong SO, Kim S, Kim SJ.   +9 more
europepmc   +1 more source